IL1B and Insulin resistance: Although canakinumab can effectively bind to IL-1β [178], it should be considered that the inflammasome also affects production of other cytokines, such as IL-18 [99,179], whose levels have been found to be strongly associated with lung function in patients with COPD and asthma [180,181] and with inflammation and insulin resistance in obese individuals [115].